References
Albrecht W, Kappenberg F, Brecklinghaus T et al (2019) Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations. Arch Toxicol 93:1609–1637. https://doi.org/10.1007/s00204-019-02492-9
Arbo MD, Melega S, Stöber R et al (2016) Hepatotoxicity of piperazine designer drugs: up-regulation of key enzymes of cholesterol and lipid biosynthesis. Arch Toxicol 90(12):3045–3060
Beliaeff B, Burgeot T (2002) Integrated biomarker response: a useful tool for ecological risk assessment. Environ Toxicol Chem 21(6):1316–1322
Chaudhari U, Nemade H, Gaspar JA, Hescheler J, Hengstler JG, Sachinidis A (2016a) MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes. Arch Toxicol 90(12):3087–3098
Chaudhari U, Nemade H, Wagh V et al (2016b) Identification of genomic biomarkers for anthracycline-induced cardiotoxicity in human iPSC-derived cardiomyocytes: an in vitro repeated exposure toxicity approach for safety assessment. Arch Toxicol 90(11):2763–2777
Colaianna M, Ilmjärv S, Peterson H et al (2017) Fingerprinting of neurotoxic compounds using a mouse embryonic stem cell dual luminescence reporter assay. Arch Toxicol 91(1):365–391. https://doi.org/10.1007/s00204-016-1690-2
Depledge MH (1994) The rational basis for the use of biomarkers as ecotoxicological tools. In: Fossi MC, Leonzio C (eds) Nondestructive biomarkers in vertebrates. Lewis, Boca Rato, pp 271–295
Frey O, Misun PM, Fluri DA, Hengstler JG, Hierlemann A (2014) Reconfigurable microfluidic hanging drop network for multi-tissue interaction and analysis. Nat Commun 5:4250. https://doi.org/10.1038/ncomms5250
Ghallab A (2017) Highlight report: metabolomics in hepatotoxicity testing. EXCLI J 21(16):1323–1325. https://doi.org/10.17179/excli2017-1041. (eCollection 2017. No abstract available)
Ghallab A, Hofmann U, Sezgin S et al (2019) Bile microinfarcts in cholestasis are initiated by rupture of the apical hepatocyte membrane and cause shunting of bile to sinusoidal blood. Hepatology 69(2):666–683
Godoy P, Hewitt NJ, Albrecht U et al (2013) Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol 87(8):1315–1530
Godoy P, Schmidt-Heck W, Natarajan K et al (2016) Gene networks and transcription factor motifs defining the differentiation of stem cells into hepatocyte-lik. J Hepatol 2015 63(4):934–942. https://doi.org/10.1016/j.jhep.2015.05.013. (Epub 2015 May 25. Erratum in: J Hepatol 2016)
Grinberg M, Stöber RM, Edlund K et al (2014) Toxicogenomics directory of chemically exposed human hepatocytes. Arch Toxicol 88(12):2261–2287
Grinberg M, Stöber RM, Albrecht W et al (2018) Toxicogenomics directory of rat hepatotoxicants in vivo and in cultivated hepatocytes. Arch Toxicol 92(12):3517–3533. https://doi.org/10.1007/s00204-018-2352-3
Gu X, Albrecht W, Edlund K et al (2018) Relevance of the incubation period in cytotoxicity testing with primary human hepatocytes. Arch Toxicol. https://doi.org/10.1007/s00204-018-2302-0. (Epub ahead of print)
Hengstler JG, Bogdanffy MS, Bolt HM, Oesch F (2003) Challenging dogma: thresholds for genotoxic carcinogens? The case of vinyl acetate. Annu Rev Pharmacol Toxicol 43:485–520
Huggett RJ, Kimerle RA, Mehrle PM, Bergman HL (1992) Biomarkers. Biochemical, physiological, and histological markers of anthropogenic stress. Lewis, Boca Raton, p 347
Jansen PL, Ghallab A, Vartak N, Reif R, Schaap FG, Hampe J, Hengstler JG (2017) The ascending pathophysiology of cholestatic liver disease. Hepatology 65(2):722–738
Leist M, Ghallab A, Graepel R et al (2017) Adverse outcome pathways: opportunities, limitations and open questions. Arch Toxicol 91(11):3477–3505. https://doi.org/10.1007/s00204-017-2045-3. (Review)
McCarty JF, Shugart LR (1990) Biomarkers of environmental contamination. Lewis, CRC, Boca Raton, p 457
Rahnenführer J, Leist M, Sachinidis A (2013) Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol 87(1):123–143. https://doi.org/10.1007/s00204-012-0967-3
Rempel E, Hoelting L, Waldmann T et al (2015) A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. Arch Toxicol 89(9):1599–1618
Rodrigues RM, Kollipara L, Chaudhari U et al (2018) Omics-based responses induced by bosentan in human hepatoma HepaRG cell cultures. Arch Toxicol 92(6):1939–1952
Sachinidis A, Albrecht W, Nell P, Cherianidou A, Hewitt NJ, Edlund K, Hengstler JG (2019) Road map for development of stem cell-based alternative test methods. Trends Mol Med 25(6):470–481. https://doi.org/10.1016/j.molmed.2019.04.003. (Review)
Shinde V, Klima S, Sureshkumar PS et al (2015) Human pluripotent stem cell based developmental toxicity assays for chemical safety screening and systems biology data generation. J Vis Exp 17(100):e52333. https://doi.org/10.3791/52333
Sisnaiske J, Hausherr V, Krug AK, Zimmer B, Hengstler JG, Leist M, van Thriel C (2014) Acrylamide alters neurotransmitter induced calcium responses in murine ESC-derived and primary neurons. Neurotoxicology 43:117–126. https://doi.org/10.1016/j.neuro.2014.03.010
Vinken M (2018a) In vitro prediction of drug-induced cholestatic liver injury: a challenge for the toxicologist. Arch Toxicol 92(5):1909–1912. https://doi.org/10.1007/s00204-018-2201-4. (No abstract available)
Vinken M (2018b) Taking adverse outcome pathways to the next level. Toxicol In Vitro 50:A1–A2
Waldmann T, Rempel E, Balmer NV et al (2014) Design principles of concentration-dependent transcriptome deviations in drug-exposed differentiating stem cells. Chem Res Toxicol 27(3):408–420
Waldmann T, Grinberg M, König A et al (2017) Stem cell transcriptome responses and corresponding biomarkers that indicate the transition from adaptive responses to cytotoxicity. Chem Res Toxicol 30(4):905–922
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author declares that he has no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bolt, H.M. Highlight Report: Adverse outcome pathways: the need of research on mechanisms of toxicity. Arch Toxicol 93, 3385–3386 (2019). https://doi.org/10.1007/s00204-019-02596-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-019-02596-2